p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB

Phytotherapy Research

Volumn 24, Issue 8, 2010, Pages 1175-1180

  An, Sang Mi ^a   Koh, Jae Sook ^b   Boo, Yong Chool ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Dermapro Ltd   (South Korea)

Author keywords

Human epidermal melanocytes; Human tyrosinase; Melanin; p coumaric acid; Tyrosine; UVB

Indexed keywords

ARBUTIN; DOPA; KOJIC ACID; MONOPHENOL MONOOXYGENASE; PARA COUMARIC ACID; TYROSINE; 4-COUMARIC ACID; COUMARIC ACID; PYRONE DERIVATIVE;

ARTICLE; CATALYSIS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; MELANOCYTE; MELANOGENESIS; MOUSE; MUSHROOM; NONHUMAN; RADIATION EXPOSURE; ULTRAVIOLET B RADIATION; AGARICALES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMICAL STRUCTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; EPIDERMIS; EXPERIMENTAL MELANOMA; METABOLISM; PIGMENTATION; ULTRAVIOLET RADIATION;

BASIDIOMYCOTA; MURINAE;

AGARICALES; ANIMALS; ARBUTIN; CELLS, CULTURED; COUMARIC ACIDS; DIHYDROXYPHENYLALANINE; EPIDERMIS; HUMANS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR STRUCTURE; MONOPHENOL MONOOXYGENASE; PIGMENTATION; PYRONES; TYROSINE; ULTRAVIOLET RAYS;

EID: 77955624111     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3095     Document Type: Article

References (34)

1. An SM, Koh JS, Boo YC. 2009. Inhibition of melanogenesis by tyrosinase siRNA in human melanocytes. BMB Rep 42: 178-183.
2. An SM, Lee SI, Choi SW, Moon SW, Boo YC. 2008. p-Coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by alpha-melanocyte stimulating hormone. Br J Dermatol 159: 292-299.
3. Ando H, Kondoh H, Ichihashi M, Hearing VJ. 2007. Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Invest Dermatol 127: 751-761. (Pubitemid 46437203)
4. Briganti S, Camera E, Picardo M. 2003. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16: 101-110. (Pubitemid 36596955)
5. Cabanes J, Chazarra S, Garcia-Carmona F. 1994. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol 46: 982-985.
6. D'Orazio JA, Nobuhisa T, Cui R, Arya M, Spry M, Wakamatsu K, Igras V, Kunisada T, Granter SR, Nishimura EK, Ito S, Fisher DE. 2006. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 443: 340-344. (Pubitemid 44435153)
7. Decker H, Schweikardt T, Tuczek F. 2006. The first crystal structure of tyrosinase: all questions answered? Angew Chem Int Ed Engl 45: 4546-4550. (Pubitemid 44106069)
8. Goding CR. 2007. Melanocytes: the new Black. Int J Biochem Cell Biol 39: 275-279.
9. Jones K, Hughes J, Hong M, Jia Q, Orndorff S. 2002. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res 15: 335-340.
10. Joshi PG, Nair N, Begum G, Joshi NB, Sinkar VP, Vora S. 2007. Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res 20: 380-384. (Pubitemid 47390112)
11. Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, Park KC. 2002. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cellular Signalling 14: 779-785.
12. Klabunde T, Eicken C, Sacchettini JC, Krebs B. 1998. Crystal structure of a plant catechol oxidase containing a dicopper center. Nat Struct Biol 5: 1084-1090. (Pubitemid 28546272)
13. Kubo I, Nihei K, Tsujimoto K. 2004. Methyl p-coumarate, a melanin formation inhibitor in B16 mouse melanoma cells. Bioorg Med Chem 12: 5349-5354. (Pubitemid 39243955)
14. Kwon BS, Haq AK, Pomerantz SH, Halaban R. 1987. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 84: 7473-7477. (Pubitemid 18035714)
15. Land EJ, Ramsden CA, Riley PA, Stratford MR. 2008. Evidence consistent with the requirement of cresolase activity for suicide inactivation of tyrosinase. Tohoku J Exp Med 216: 231-238.
16. Lee SI, Kim HJ, Baek MC, Park KM, Park Y, Yoon CH, Boo YC. 2007. Wen-pi-tang-Hab-Wu-ling-san, an oriental herbal prescription, attenuates epithelial-mesenchymal transdifferentiation stimulated by TGF-beta1 in kidney cells. Phytother Res 21: 548-553. (Pubitemid 46910231)
17. Lerch K. 1978. Amino acid sequence of tyrosinase from Neurospora crassa. Proc Natl Acad Sci USA 75: 3635-3639. (Pubitemid 8399901)
18. Lim JY, Ishiguro K, Kubo I. 1999. Tyrosinase inhibitory p-coumaric acid from ginseng leaves. Phytother Res 13: 371-375. (Pubitemid 29401384)
19. Maeda K, Fukuda M. 1996. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 276: 765-769.
20. Munoz-Munoz JL, Garcia-Molina F, Garcia-Ruiz PA, Molina- Alarcon M, Tudela J, Garcia-Canovas F, Rodriguez-Lopez JN. 2008. Phenolic substrates and suicide inactivation of tyrosinase: kinetics and mechanism. Biochem J 416: 431-440.
21. Nakai N, Kishida T, Shin-Ya M, Imanishi J, Ueda Y, Kishimoto S, Mazda O. 2007. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene Ther 14: 357-365. (Pubitemid 46231929)
22. Park SH, Kim DS, Park SH, Shin JW, Youn SW, Park KC. 2008. Inhibitory effect of p-coumaric acid by Rhodiola sachalinensis on melanin synthesis in B16F10 cells. Pharmazie 63: 290-295.
23. Parvez S, Kang M, Chung HS, Bae H. 2007. Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries. Phytother Res 21: 805-816. (Pubitemid 47407639)
24. Parvez S, Kang M, Chung HS, Cho C, Hong MC, Shin MK, Bae H. 2006. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res 20: 921-934. (Pubitemid 44767486)
25. Riley PA. 1999. The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis. Cell Mol Biol (Noisy-le-grand) 45: 951-960.
26. Schwahn DJ, Xu W, Herrin AB, Bales ES, Medrano EE. 2001. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation. Pigment Cell Res 14: 32-39.
27. Slominski A. 2002. Coming of age of melanogenesis-related proteins. Arch Pathol Lab Med 126: 775-777.
28. Slominski A, Moellmann G, Kuklinska E, Bomirski A, Pawelek J. 1988. Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa. J Cell Sci 89(3): 287-296. (Pubitemid 18094890)
29. Slominski A, Tobin DJ, Shibahara S, Wortsman J. 2004. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84: 1155-1228. (Pubitemid 39287950)
30. Solano F, Briganti S, Picardo M, Ghanem G. 2006. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 19: 550-571. (Pubitemid 44674109)
31. Sulaimon SS, Kitchell BE. 2003. The biology of melanocytes. Vet Dermatol 14: 57-65.
32. Takara K, Iwasaki H, Ujihara K, Wada K. 2008. Human tyrosinase inhibitor in rum distillate wastewater. J Oleo Sci 57: 191-196.
33. Wickelgren I. 2007. Skin biology. A healthy tan? Science 315: 1214-1216.
34. Yamaguchi Y, Beer JZ, Hearing VJ. 2008. Melanin mediated apoptosis of epidermal cells damaged by ultraviolet radiation: factors influencing the incidence of skin cancer. Arch Dermatol Res 300(S1): S43-S50.